Ben Richardson, CEO at SulNOx, confident they can cost-effectively decarbonise commercial shipping. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksHutchmed Share News (HCM)

Share Price Information for Hutchmed (HCM)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 300.00
Bid: 0.00
Ask: 0.00
Change: 0.00 (0.00%)
Spread: 1.00 (0.334%)
Open: 0.00
High: 0.00
Low: 0.00
Prev. Close: 300.00
HCM Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

UK shareholder meetings calendar - next 7 days

Wed, 21st Apr 2021 16:02

Thursday 22 April 
Aggreko PLCAGM
Alliance Trust PLCAGM
Bidstack Group PLCAGM
CLS Holdings PLCAGM
Dignity  PLCGM re proposal to remove Clive Whiley as executive chair
Domino's Pizza Group PLCAGM
Foxtons PLCAGM
Ibstock PLCAGM
GLI Finance LtdEGM re tender offer for ZDP shares
JPMorgan Claverhouse Investment Trust PLCAGM
National Grid PLCGM re PPL WPD acquisition
RELX PLCAGM
RIT Capital Partners PLCAGM
Segro PLCAGM
SThree PLCAGM
Taylor Wimpey PLCAGM
Tullow Oil PLCAGM
Friday 23 April 
BB Healthcare Trust PLCAGM
Beeks Financial Cloud Group PLCGM re fundraising
Faron Pharmaceuticals OyAGM
Hikma Pharmaceuticals PLCAGM
INVESCO Income Growth Trust PLCGM re voluntary wind up
Minds + Machines Group LtdGM re sale of assets to GoDaddy Inc
Senior PLCAGM
Monday 26 April 
Aggreko PLCGM re takeover by Albion Acquisitions
Hostelworld Group PLCGM re director remuneration policy
Polymetal International PLCAGM
Tuesday 27 April 
Synectics PLCAGM
Aquis Exchange PLCAGM
Diversified Gas & Oil PLCAGM
Tribal Group PLCAGM
Travis Perkins PLCAGM
Wednesday 28 April 
British American Tobacco PLCAGM
Caerus Mineral Resources PLCGM re acquisition of PR Ploutonic Resources Ltd
Capital LtdAGM
CPPGroup PLCAGM
Eurasia Mining PLCEGM re general power to allot securities
FDM Group PLCAGM
Fintel PLCAGM
Global Invacom Group LtdAGM
Grafton Group PLCAGM
Greencoat UK Wind PLCAGM
Hutchison China MediTech LtdAGM
KRM22 PLCAGM
London Stock Exchange Group PLCAGM
Mobius Investment Trust PLCAGM
NatWest Group PLCAGM
Nichols PLCAGM
Pendragon PLCAGM
Pershing Square Holdings LtdAGM
Persimmon PLCAGM
RPS Group PLCAGM
Spirent Communications PLCAGM
Witan Investment Trust PLCAGM
  
Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
28 Oct 2021 21:59

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

IN BRIEF: Hutchmed begins phase 3 trial of thrombocytopenia drug

Read more
29 Sep 2021 11:08

Hutchmed China sells joint venture stake for USD169 million

Hutchmed China sells joint venture stake for USD169 million

Read more
21 Sep 2021 10:51

Hutchmed starts drug combination trial for neuroendocrine tumours

Hutchmed starts drug combination trial for neuroendocrine tumours

Read more
20 Sep 2021 09:09

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Hutchmed starts Japan trial for surufatinib in neuroendocrine tumors

Read more
13 Sep 2021 10:22

Hutchmed China's amdizalisib secures breakthrough therapy designation

Hutchmed China's amdizalisib secures breakthrough therapy designation

Read more
8 Sep 2021 13:49

Hutchmed, Astra launch drug combination trial to treat lung cancer

Hutchmed, Astra launch drug combination trial to treat lung cancer

Read more
6 Sep 2021 09:37

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Hutchmed China to trade in Shanghai and Shenzhen through link scheme

Read more
26 Aug 2021 10:38

Hutchmed launches trial into drug combination to treat breast cancer

Hutchmed launches trial into drug combination to treat breast cancer

Read more
9 Aug 2021 12:35

Hutchmed strikes collaboration deal with Epizyme

(Sharecast News) - Commercial-stage biotechnology company Hutchmed China announced a collaboration to research, develop, manufacture and commercialise 'Tazverik' in Greater China on Monday, including mainland China, Hong Kong, Macau and Taiwan.

Read more
9 Aug 2021 10:06

Hutchmed to partner with Epizyme on tumour-targetting treatment

Hutchmed to partner with Epizyme on tumour-targetting treatment

Read more
28 Jul 2021 14:51

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Hutchmed research costs deepen loss; expects US launches in 2022, 2023

Read more
28 Jul 2021 11:33

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

IN BRIEF: Hutchmed and AstraZeneca launch phase two cancer med trial

Read more
28 Jul 2021 10:58

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

AIM WINNERS & LOSERS: Hutchmed notes phase 2 trial; Tricorn drops 25%

Read more
21 Jul 2021 16:12

UK earnings, trading statements calendar - next 7 days

UK earnings, trading statements calendar - next 7 days

Read more
16 Jul 2021 11:19

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

AIM WINNERS & LOSERS: Pantheon up on resource upgrade, farmout talks

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.